Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia...

Area of Science:

• Endocrinology
• Diabetes Management
• Emergency Medicine

Background:

• Severe hypoglycemia poses a critical risk for individuals with diabetes, often necessitating assistance from others for treatment.
• Current treatment options, such as injectable glucagon, can be challenging for untrained individuals to administer effectively during emergencies.

Purpose of the Study:

• To compare the ease of use between needle-free nasal glucagon and traditional injectable glucagon for treating simulated severe hypoglycemia episodes.
• To evaluate the efficacy of these glucagon formulations when administered by laypersons, including caregivers and acquaintances.

Main Methods:

• A simulation study involving 16 instructed caregivers and 15 non-instructed acquaintances.
• Participants administered both nasal and injectable glucagon to manikins simulating unconscious individuals experiencing severe hypoglycemia.

Main Results:

• Over 90% of participants successfully administered a full dose of nasal glucagon, with a mean administration time under 0.5 minutes.
• In contrast, only 13% of caregivers and 0% of acquaintances administered a full dose of injectable glucagon, with significantly longer administration times and frequent errors.
• Common errors with injectable glucagon included administering diluent only, needle bending, and confusing it with insulin.

Conclusions:

• Nasal glucagon demonstrates superior ease of use and higher success rates for full-dose administration by non-medically trained individuals compared to injectable glucagon.
• Nasal glucagon offers a promising alternative to improve the timely and effective treatment of severe hypoglycemia, potentially enhancing patient safety during life-threatening episodes.